Insomnia in men treated with radical prostatectomy for prostate cancer

Psycho-oncology
Josée SavardYves Fradet

Abstract

This study assessed the prevalence, clinical characteristics and risk factors for insomnia in patients treated with radical prostatectomy for prostate cancer. A total of 327 patients completed a battery of questionnaires assessing sleep and related issues (i.e. anxiety, depression, fatigue, quality of life). Results indicated that 31.5% of the patients currently reported non-specific sleep difficulties, while 18% met specific criteria for an insomnia syndrome. In most of these latter cases (95%), the insomnia was chronic (duration of 6 months or more). Nearly half of patients with an insomnia syndrome reported that the onset of their sleep difficulties followed the cancer diagnosis. A similar proportion had no comorbid clinical levels of anxiety or depression. Risk factors for the presence of an insomnia syndrome included a younger age, a worse prognosis, and the presence of intestinal, pain, depressive, and androgen blockade-related symptoms. Thus, insomnia is a frequent problem associated with prostate cancer, that often occurs independently of anxiety and depression, but seems to be influenced by the presence of physical and psychological symptoms associated with prostate cancer and its treatment.

References

Mar 1, 1985·Archives of General Psychiatry·G D MellingerE H Uhlenhuth
Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Apr 1, 1995·Journal of Psychosomatic Research·E M SmetsJ C De Haes
Sep 1, 1994·Sleep·S Woodward, R R Freedman
Jun 1, 1994·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·R K PortenoyW Hoskins
Apr 1, 1996·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·G Borghede, M Sullivan
May 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A BroeckelG H Lyman
Feb 6, 1999·Journal of Personality Assessment·J SavardM G Bergeron
Mar 31, 1999·International Journal of Radiation Oncology, Biology, Physics·W LillebyD R Olsen
May 5, 2000·Digestive Diseases and Sciences·M JarrettV Hertig
Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Savard, C M Morin
May 1, 2002·Current Opinion in Oncology·Brian I Rini, Eric J Small
Jun 13, 2002·Social Science & Medicine·Judith R DavidsonKarleen Schulze
Oct 3, 2002·The American Journal of Gastroenterology·Sigrid ElsenbruchWilliam C Orr
Jan 18, 2003·Sleep Medicine Reviews·Christina S. McCrae, Kenneth L. Lichstein
Jan 18, 2003·Sleep Medicine Reviews·Maurice M Ohayon
Mar 5, 2003·Journal of Pain and Symptom Management·Steven D PassikDale E Theobald
Jun 18, 2003·World Journal of Urology·W F StewartA J Wein
May 29, 2004·Journal of Pain and Symptom Management·Josée SavardCharles M Morin
Sep 18, 2004·Psycho-oncology·Marie-Hélène SavardHans Ivers

❮ Previous
Next ❯

Citations

Aug 9, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Christopher G LisJames F Grutsch
Feb 7, 2009·Journal of Psychosocial Oncology·Ann BoonzaierPenelope Schofield
Jul 16, 2010·The Journal of Sexual Medicine·Stacy ElliottUNKNOWN ADT Survivorship Working Group
Jan 19, 2010·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Christina Van OnselenChristine Miaskowski
Jul 21, 2009·Applied Nursing Research : ANR·Shannon Ruff DirksenMichael A Hoyt
Dec 10, 2015·Behavioral Sleep Medicine·Gregory S Vander WalCynthia K Perkins
May 22, 2007·Seminars in Oncology Nursing·Kristine A Donovan, Paul B Jacobsen
May 1, 2007·Journal of Psychosomatic Research·Kyriaki MystakidouLambros Vlahos
Nov 7, 2006·Psycho-oncology·Tatsuo AkechiYosuke Uchitomi
Dec 17, 2009·Psycho-oncology·Leanne FlemingColin A Espie
Oct 17, 2009·European Journal of Cancer Care·N Humpel, D C Iverson
Sep 10, 2010·European Journal of Cancer Care·L J HanischJ C Coyne
May 16, 2006·Urology·Frank J PenedoMichael H Antoni
Feb 18, 2015·Clinical Journal of Oncology Nursing·Genevieve A DesaulniersKaren Wasilewski-Masker
Apr 30, 2013·Brain, Behavior, and Immunity·Michael A HoytMichael R Irwin
Nov 6, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jun TianHai Rong Zhang
Sep 21, 2010·International Journal of Psychiatry in Medicine·Cherise B HarringtonMichael Feuerstein
Jun 18, 2015·PloS One·Yajing HeYang Liu
Aug 9, 2016·Journal of Cancer Survivorship : Research and Practice·Eric S ZhouChristopher J Recklitis
Sep 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Josée SavardCharles M Morin
Aug 10, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Josée SavardCharles M Morin
Jun 6, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Brian D GonzalezSiu-Kuen Azor Hui
Feb 6, 2009·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Michael A HoytShannon R Dirksen
Oct 10, 2014·The Cancer Journal·J Keith Mansel, Elise C Carey
Aug 1, 2007·The Oncologist·Joseph A RoscoeGary R Morrow
Jan 18, 2019·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Yi-Zhong ChenWei-Kung Tsai
Jan 11, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Rebecca MaguireLinda Sharp
Oct 30, 2020·Cancer Treatment and Research Communications·Shenyll DelpachitraErik Wibowo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Social Science & Medicine
Judith R DavidsonKarleen Schulze
Journal of Psychosomatic Research
Janet S Carpenter, M A Andrykowski
Journal of Pain and Symptom Management
Barry V FortnerH Heith Durrence
© 2021 Meta ULC. All rights reserved